MLTX Straddle Strategy
MLTX (MoonLake Immunotherapeutics), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or radiographic axial spondyloarthritis. MoonLake Immunotherapeutics was founded in 2021 and is headquartered in Zug, Switzerland.
MLTX (MoonLake Immunotherapeutics) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $1.36B, a beta of 1.01 versus the broader market, a 52-week range of 5.95-62.75, average daily share volume of 1.2M, a public-listing history dating back to 2020, approximately 100 full-time employees. These structural characteristics shape how MLTX stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 1.01 places MLTX roughly in line with broader market moves, so the strategy payoff and realized volatility track the index-equivalent baseline.
What is a straddle on MLTX?
A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration.
Current MLTX snapshot
As of May 15, 2026, spot at $17.54, ATM IV 74.60%, IV rank 18.27%, expected move 21.39%. The straddle on MLTX below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.
Why this straddle structure on MLTX specifically: MLTX IV at 74.60% is on the cheap side of its 1-year range, which favors premium-buying structures like a MLTX straddle, with a market-implied 1-standard-deviation move of approximately 21.39% (roughly $3.75 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated MLTX expiries trade a higher absolute premium for lower per-day decay. Position sizing on MLTX should anchor to the underlying notional of $17.54 per share and to the trader's directional view on MLTX stock.
MLTX straddle setup
The MLTX straddle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With MLTX near $17.54, the first option leg uses a $18.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed MLTX chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 MLTX shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 1 | Call | $18.00 | $1.50 |
| Buy 1 | Put | $18.00 | $1.83 |
MLTX straddle risk and reward
- Net Premium / Debit
- -$332.50
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- -$331.06
- Breakeven(s)
- $14.68, $21.33
- Risk / Reward Ratio
- Unbounded
Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit.
MLTX straddle payoff curve
Modeled P&L at expiration across a range of underlying prices for the straddle on MLTX. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
| Underlying Price | % From Spot | P&L at Expiration |
|---|---|---|
| $0.01 | -99.9% | +$1,466.50 |
| $3.89 | -77.8% | +$1,078.79 |
| $7.76 | -55.7% | +$691.08 |
| $11.64 | -33.6% | +$303.37 |
| $15.52 | -11.5% | -$84.33 |
| $19.40 | +10.6% | -$192.96 |
| $23.27 | +32.7% | +$194.75 |
| $27.15 | +54.8% | +$582.46 |
| $31.03 | +76.9% | +$970.17 |
| $34.90 | +99.0% | +$1,357.88 |
When traders use straddle on MLTX
Straddles on MLTX are pure-volatility plays that profit from large moves in either direction; traders typically buy MLTX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
MLTX thesis for this straddle
The market-implied 1-standard-deviation range for MLTX extends from approximately $13.79 on the downside to $21.29 on the upside. A MLTX long straddle is a pure-volatility play: it profits when the underlying moves far enough from the strike in either direction to overcome the combined call plus put debit, regardless of direction. Current MLTX IV rank near 18.27% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on MLTX at 74.60%. As a Healthcare name, MLTX options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to MLTX-specific events.
MLTX straddle positions are structurally neutral / high-volatility (long premium); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. MLTX positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move MLTX alongside the broader basket even when MLTX-specific fundamentals are unchanged. Always rebuild the position from current MLTX chain quotes before placing a trade.
Frequently asked questions
- What is a straddle on MLTX?
- A straddle on MLTX is the straddle strategy applied to MLTX (stock). The strategy is structurally neutral / high-volatility (long premium): A long straddle buys an ATM call and an ATM put at the same strike, profiting from a large move in either direction; max loss equals the combined debit when the underlying pins to the strike at expiration. With MLTX stock trading near $17.54, the strikes shown on this page are snapped to the nearest listed MLTX chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are MLTX straddle max profit and max loss calculated?
- Upside max profit is unbounded; downside max profit is bounded at the strike minus the combined call plus put debit (reached at zero). Max loss equals the combined debit times 100 (reached when the underlying pins to the strike). Two breakevens at strike plus debit and strike minus debit. For the MLTX straddle priced from the end-of-day chain at a 30-day expiry (ATM IV 74.60%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$331.06 per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a MLTX straddle?
- The breakeven for the MLTX straddle priced on this page is roughly $14.68 and $21.33 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current MLTX market-implied 1-standard-deviation expected move is approximately 21.39%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a straddle on MLTX?
- Straddles on MLTX are pure-volatility plays that profit from large moves in either direction; traders typically buy MLTX straddles ahead of earnings, FDA decisions, or other catalysts where the realized move is expected to exceed the implied move priced into the chain.
- How does current MLTX implied volatility affect this straddle?
- MLTX ATM IV is at 74.60% with IV rank near 18.27%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.